The Clorox Company (CLX) trades at a trailing P/E of 17.0, forward P/E of 17.7. Trailing earnings yield is 5.88%, forward earnings yield 5.64%. PEG 0.09 (Peter Lynch undervalued ≤1.0). Graham Number is $6.34.
Criteria proven by this page:
Overall SharesGrow Score: 66/100 with 4/7 criteria passed.
| Year | P/E (TTM) | PEG Ratio | P/B Ratio | P/S Ratio | Dividend Yield |
|---|---|---|---|---|---|
| 2016 | 27.7 | 2.20 | 60.33 | 3.11 | 2.22% |
| 2017 | 24.5 | 2.92 | 31.70 | 2.88 | 2.40% |
| 2018 | 21.2 | 1.23 | 24.09 | 2.86 | 2.57% |
| 2019 | 23.8 | 30.32 | 34.92 | 3.14 | 2.51% |
| 2020 | 29.4 | 1.81 | 30.40 | 4.11 | 1.93% |
| 2021 | 31.8 | -1.31 | 54.97 | 3.08 | 2.47% |
| 2022 | 37.6 | -1.12 | 31.22 | 2.44 | 3.29% |
| 2023 | 131.9 | -1.95 | 89.34 | 2.66 | 2.97% |
| 2024 | 59.5 | 0.69 | 50.82 | 2.35 | 3.57% |
| 2025 | 18.3 | 0.10 | 46.20 | 2.09 | 4.06% |
| Year | EPS (Diluted) | Revenue | Net Income | Net Margin |
|---|---|---|---|---|
| 2016 | $4.92 | $5.76B | $648M | 11.2% |
| 2017 | $5.33 | $5.97B | $701M | 11.7% |
| 2018 | $6.25 | $6.12B | $823M | 13.4% |
| 2019 | $6.32 | $6.21B | $820M | 13.2% |
| 2020 | $7.35 | $6.72B | $939M | 14% |
| 2021 | $5.58 | $7.34B | $710M | 9.7% |
| 2022 | $3.73 | $7.11B | $462M | 6.5% |
| 2023 | $1.20 | $7.39B | $149M | 2% |
| 2024 | $2.25 | $7.09B | $280M | 3.9% |
| 2025 | $6.52 | $7.1B | $810M | 11.4% |
| Year | EPS (Avg) | EPS Range | Revenue (Avg) | Revenue Range | Analysts |
|---|---|---|---|---|---|
| 2026 | $5.91 | $5.65 – $6.15 | $6.52B | $6.39B – $6.69B | 11 |
| 2027 | $6.77 | $6.60 – $7.00 | $7.05B | $6.65B – $7.51B | 8 |
| 2028 | $7.20 | $7.04 – $7.36 | $7.25B | $7.14B – $7.37B | 2 |
| 2029 | $7.80 | $7.61 – $7.99 | $7.64B | $7.44B – $7.89B | 1 |
| 2030 | $8.16 | $7.96 – $8.36 | $7.84B | $7.64B – $8.1B | 1 |
